Published in Cancer Weekly, February 10th, 1997
Despite numerous reports of clinical trials demonstrating decreased breast cancer mortality for women aged 40-49 through mammographic screening, said the ACS, the conference Panel concluded "that the available data do not warrant a single recommendation for mammography for all women in their forties."
The report also places undue emphasis on issues such as radiation risk, anxiety caused by false positive...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1997-02-10)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.